Abstract Details
|
Brendan J. Kelley, MD, FAAN
(University of Texas Southwestern)
PRESENTER |
Dr. Kelley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Labcorp. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. |
| No disclosure on file | |
| Frederick W. Unverzagt, PhD (Indiana Univ. School of Medicine) | No disclosure on file |
| Brett M. Kissela, MD, MS, FAAN (University of Cincinnati Hospital) | The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities. |
| Dawn O. Kleindorfer, MD, FAAN (University of Michigan Department of Neurology) | Dr. Kleindorfer has nothing to disclose. |
| George Howard, PhD (UAB School of Public Hlth) | Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. |
| No disclosure on file |